These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26596217)

  • 61. Expression of α-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions.
    Morel E; Alvarez L; Cabañas R; Fiandor A; Díaz R; Escamochero S; Prior N; Blanca M; Bellón T
    Allergy; 2011 Mar; 66(3):360-7. PubMed ID: 20880148
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interleukin-2 in the development and control of inflammatory disease.
    Hoyer KK; Dooms H; Barron L; Abbas AK
    Immunol Rev; 2008 Dec; 226():19-28. PubMed ID: 19161413
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction.
    Paquet P; Arrese JE; Beguin Y; Piérard GE
    Curr Top Pathol; 2001; 94():49-63. PubMed ID: 11443887
    [No Abstract]   [Full Text] [Related]  

  • 64. The yin and yang of regulatory T cells and inflammation in RA.
    Notley CA; Ehrenstein MR
    Nat Rev Rheumatol; 2010 Oct; 6(10):572-7. PubMed ID: 20808295
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Proportion of CD4
    Kim J; Lee J; Gonzalez J; Fuentes-Duculan J; Garcet S; Krueger JG
    J Invest Dermatol; 2018 Dec; 138(12):2669-2672. PubMed ID: 29890167
    [No Abstract]   [Full Text] [Related]  

  • 66. Loss of Regulatory Immune Function in Coronary Artery Disease Patients from the Indian Population.
    Ponnusamy T; Komarulu Venkatachala S; Ramanujappa M; Mundkur L
    J Cardiovasc Transl Res; 2019 Aug; 12(4):378-388. PubMed ID: 30811027
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia.
    Perry C; Herishanu Y; Hazan-Halevy I; Kay S; Bdolach N; Naparstek E; Polliack A; Grisaru D
    Leuk Lymphoma; 2012 Sep; 53(9):1807-10. PubMed ID: 22242820
    [No Abstract]   [Full Text] [Related]  

  • 68. Decreased circulating T regulatory lymphocytes in obese patients undergoing bariatric surgery.
    Agabiti-Rosei C; Trapletti V; Piantoni S; Airò P; Tincani A; De Ciuceis C; Rossini C; Mittempergher F; Titi A; Portolani N; Caletti S; Coschignano MA; Porteri E; Tiberio GAM; Pileri P; Solaini L; Kumar R; Ministrini S; Agabiti Rosei E; Rizzoni D
    PLoS One; 2018; 13(5):e0197178. PubMed ID: 29758052
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytokines/Chemokines: Novel Biomarkers Associated with Severe Cutaneous Adverse Reactions.
    Zhang X; Lu WS; Qin XM
    J Interferon Cytokine Res; 2020 Apr; 40(4):172-181. PubMed ID: 32195616
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Drug-dependent binding of circulating antibodies in drug-induced toxic epidermal necrolysis.
    Hensen EJ; Claas FH; Vermeer BJ
    Lancet; 1981 Jul; 2(8238):151-2. PubMed ID: 6113511
    [No Abstract]   [Full Text] [Related]  

  • 71. SEB Stimulation Induces Functional Pathogenic Features in Th17 Cells from Psoriasis Patients.
    Castro-Escamilla O; Aguilar-Flores C; Mora-Velandia LM; Morán-Martínez K; Fernández-Madinaveitia DE; Lemini-López A; González-Palacios E; Maldonado-García C; Jurado-Santa Cruz F; Pérez-Montesinos G; Bonifaz LC
    J Invest Dermatol; 2018 Dec; 138(12):2677-2681. PubMed ID: 29890166
    [No Abstract]   [Full Text] [Related]  

  • 72. Demonstration of basal cell immunofluorescence in drug-induced toxic epidermal necrolysis.
    Stein KM; Schlappner OL; Heaton CL; Decherd JW
    Br J Dermatol; 1972 Mar; 86(3):246-52. PubMed ID: 4553158
    [No Abstract]   [Full Text] [Related]  

  • 73. Galectin-7 as a potential biomarker of Stevens-Johnson syndrome/toxic epidermal necrolysis: identification by targeted proteomics using causative drug-exposed peripheral blood cells.
    Hama N; Nishimura K; Hasegawa A; Yuki A; Kume H; Adachi J; Kinoshita M; Ogawa Y; Nakajima S; Nomura T; Watanabe H; Mizukawa Y; Tomonaga T; Shimizu H; Abe R
    J Allergy Clin Immunol Pract; 2019; 7(8):2894-2897.e7. PubMed ID: 31100551
    [No Abstract]   [Full Text] [Related]  

  • 74. Toxic epidermal necrolysis.
    Ammann AJ; Tooley WH; Hong R
    Lancet; 1972 Sep; 2(7775):484-5. PubMed ID: 4115367
    [No Abstract]   [Full Text] [Related]  

  • 75. Staphylococcal toxic epidermal necrolysis: pathogenesis and studies on the subcellular site of action of exfoliatin.
    Elias PM; Fritsch P; Dahl MV; Wolff K
    J Invest Dermatol; 1975 Dec; 65(6):501-12. PubMed ID: 1194714
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Delayed hypersensitivity in drug-induced toxic epidermal necrolysis (TEN).
    Wolf R; Livni E; Joshua H
    Arch Dermatol; 1984 Dec; 120(12):1555. PubMed ID: 6508326
    [No Abstract]   [Full Text] [Related]  

  • 77. Lymphocyte transformation test in drug-induced toxic epidermal necrolysis.
    Roujeau JC; Albengres E; Moritz S; Piacentino A; Cuny M; Revuz J; Touraine R
    Int Arch Allergy Appl Immunol; 1985; 78(1):22-4. PubMed ID: 3875565
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Letter: Staphylococcal scalded skin syndrome in adults.
    Elias PM
    Arch Dermatol; 1974 Aug; 110(2):295-6. PubMed ID: 4852933
    [No Abstract]   [Full Text] [Related]  

  • 79. Looking Beyond Th17 Cells: A Role for Tr1 Cells in Ankylosing Spondylitis?
    McGinty J; Brittain N; Kenna TJ
    Front Immunol; 2020; 11():608900. PubMed ID: 33343582
    [No Abstract]   [Full Text] [Related]  

  • 80. Depletion of regulatory FoxP3
    Amakata M; Teraki Y
    Int J Dermatol; 2019 Dec; 58(12):e247-e249. PubMed ID: 31334834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.